报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 9.27% | 130.79% | -58.34% | 1/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
2024-12-31 | 22.26% | 106.44% | 312.57% | 1/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
2024-09-30 | -10.47% | 89.48% | 86.76% | 65/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
2024-06-30 | -79.09% | -29.22% | -162.56% | 67/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
2024-03-31 | -30.12% | -118.54% | 91.29% | 68/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
2023-12-31 | -345.88% | -469.63% | -247.52% | 68/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
2022-09-30 | -99.53% | -329.37% | -62.61% | 68/71 | 5.07% | 太极集团 | 22.08% | 行业排名> |
2022-06-30 | -61.21% | -310.52% | -344.04% | 68/71 | 3.13% | 太极集团 | 17.13% | 行业排名> |
2022-03-31 | -13.78% | -220.27% | 77.3% | 67/71 | 2.15% | 以岭药业 | 10.43% | 行业排名> |
2021-12-31 | -60.72% | 3.24% | -161.95% | 67/71 | 4.45% | *ST吉药 | 72.63% | 行业排名> |
2021-09-30 | -23.18% | -485.55% | -55.48% | 66/71 | 7.44% | 片仔癀 | 19.69% | 行业排名> |
2021-06-30 | -14.91% | -60.8% | -246.42% | 67/71 | 4.61% | 片仔癀 | 12.75% | 行业排名> |
2021-03-31 | -4.3% | -18371.24% | 93.14% | 65/71 | -2.87% | 片仔癀 | 6.88% | 行业排名> |
2020-12-31 | -62.75% | -54.18% | -1485.12% | 67/71 | -2.08% | 片仔癀 | 27.39% | 行业排名> |
2020-09-30 | -3.96% | 2.74% | 57.3% | 67/71 | 5.56% | 片仔癀 | 23.14% | 行业排名> |
2020-06-30 | -9.27% | 49.52% | -39693.13% | 66/71 | 3.25% | 片仔癀 | 13.23% | 行业排名> |
2020-03-31 | -0.02% | 99.31% | 99.94% | 59/71 | 1.91% | *ST长药 | 7.37% | 行业排名> |
2019-12-31 | -40.7% | 24.26% | -899.93% | 67/71 | 3.89% | 沃华医药 | 22.84% | 行业排名> |
2019-09-30 | -4.07% | -138.11% | 77.84% | 63/71 | 7.09% | 沃华医药 | 19.47% | 行业排名> |
2019-06-30 | -18.37% | -93.15% | -442.14% | 66/71 | 4.58% | 沃华医药 | 12.7% | 行业排名> |
2019-03-31 | -3.39% | -18.88% | 93.7% | 64/71 | 2.86% | 济川药业 | 7.33% | 行业排名> |
2018-12-31 | -53.74% | -110.42% | -603.18% | 69/71 | 7.68% | 济川药业 | 27.43% | 行业排名> |
2018-09-30 | 10.68% | -20.9% | 212.3% | 16/71 | 7.89% | 济川药业 | 23.05% | 行业排名> |
2018-06-30 | -9.51% | 36.31% | -233.68% | 65/71 | 4.92% | 济川药业 | 15.79% | 行业排名> |
2018-03-31 | -2.85% | 47.1% | 88.84% | 65/71 | 2.71% | 华润三九 | 10.23% | 行业排名> |
2017-12-31 | -25.54% | -4.29% | -289.15% | 68/71 | 9.76% | 济川药业 | 32.79% | 行业排名> |
2017-09-30 | 13.5% | 1717.84% | 190.43% | 9/71 | 8.29% | 济川药业 | 27.55% | 行业排名> |
2017-06-30 | -14.93% | 30.59% | -177.14% | 65/71 | 5.16% | 济川药业 | 17.62% | 行业排名> |
2017-03-31 | -5.39% | 40.38% | 78% | 62/71 | 2.6% | 济川药业 | 10.07% | 行业排名> |
2016-12-31 | -24.49% | 22.91% | -2834.34% | 66/71 | 9.95% | ST葫芦娃 | 46.01% | 行业排名> |
2016-09-30 | -0.83% | 95.17% | 96.12% | 59/71 | 9.31% | 济川药业 | 24.2% | 行业排名> |
2016-06-30 | -21.51% | -162.7% | -138.08% | 64/71 | 5.02% | *ST大药 | 15.31% | 行业排名> |
2016-03-31 | -9.04% | -105.76% | 71.56% | 58/71 | 4.04% | 济川药业 | 14.64% | 行业排名> |
2015-12-31 | -31.77% | -1141.64% | -83.68% | 65/71 | 11.27% | 济川药业 | 7.64% | 行业排名> |
2015-09-30 | -17.3% | -725.47% | -111.21% | 56/71 | 8.43% | 维康药业 | 38.23% | 行业排名> |
2015-06-30 | -8.19% | -516.72% | -86.47% | 56/71 | 5.48% | 太极集团 | 58.41% | 行业排名> |
2015-03-31 | -4.39% | -409.61% | -243.99% | 56/71 | 2.93% | 新光药业 | 16.54% | 行业排名> |